DE69942581D1 - Verfahren zur herstellung einer nucleinsäure enthaltenden kompositzusammenstellung - Google Patents
Verfahren zur herstellung einer nucleinsäure enthaltenden kompositzusammenstellungInfo
- Publication number
- DE69942581D1 DE69942581D1 DE69942581T DE69942581T DE69942581D1 DE 69942581 D1 DE69942581 D1 DE 69942581D1 DE 69942581 T DE69942581 T DE 69942581T DE 69942581 T DE69942581 T DE 69942581T DE 69942581 D1 DE69942581 D1 DE 69942581D1
- Authority
- DE
- Germany
- Prior art keywords
- producing
- nucleic acid
- composition
- cationic carrier
- stranded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14276398 | 1998-05-25 | ||
PCT/JP1999/002713 WO1999061032A1 (fr) | 1998-05-25 | 1999-05-24 | Procede de production d'une preparation composite contenant de l'acide nucleique |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69942581D1 true DE69942581D1 (de) | 2010-08-26 |
Family
ID=15323024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69942581T Expired - Lifetime DE69942581D1 (de) | 1998-05-25 | 1999-05-24 | Verfahren zur herstellung einer nucleinsäure enthaltenden kompositzusammenstellung |
Country Status (10)
Country | Link |
---|---|
US (2) | US6545138B1 (de) |
EP (1) | EP1086699B1 (de) |
JP (1) | JP3785932B2 (de) |
KR (1) | KR100644172B1 (de) |
CN (1) | CN1166366C (de) |
AT (1) | ATE473748T1 (de) |
CA (1) | CA2333162C (de) |
DE (1) | DE69942581D1 (de) |
RU (1) | RU2222334C2 (de) |
WO (1) | WO1999061032A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1435389A4 (de) * | 2001-09-04 | 2006-02-22 | Nippon Shinyaku Co Ltd | Verfahren zur bewertung der wirksamkeit einer nukleinsäuretherapie |
GB0127832D0 (en) * | 2001-11-20 | 2002-01-09 | Jagotec Ag | Method for the preparation of pharmaceutical nanosuspensions |
US7381422B2 (en) | 2002-12-23 | 2008-06-03 | Vical Incorporated | Method for producing sterile polynucleotide based medicaments |
WO2004105774A1 (ja) * | 2003-05-30 | 2004-12-09 | Nippon Shinyaku Co., Ltd. | オリゴ核酸担持複合体、当該複合体を含有する医薬組成物 |
US20080020990A1 (en) * | 2003-05-30 | 2008-01-24 | Nippon Shinyaku Co., Ltd. | Oligo Double-Stranded Rna Inhibiting the Expression of Bcl-2 and Pharmaceutical Composition Containing the Same |
US20090069260A1 (en) * | 2005-05-30 | 2009-03-12 | Nippon Shinyaku Co., Ltd | Method for producing a nucleic-acid-containing complex preparation |
US20080271995A1 (en) * | 2007-05-03 | 2008-11-06 | Sergey Savastiouk | Agitation of electrolytic solution in electrodeposition |
WO2012129767A1 (zh) * | 2011-03-28 | 2012-10-04 | 南京大学 | 阳离子修饰的琼脂糖水凝胶和核酸药物组合物及制法和应用 |
WO2015173824A1 (en) | 2014-05-14 | 2015-11-19 | Alex Levitzki Management And Holdings Ltd | Improved polyethyleneimine polyethyleneglycol vectors |
CN109355334A (zh) * | 2018-12-06 | 2019-02-19 | 江苏省农业科学院 | 一种制备聚肌胞的方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA805716B (en) * | 1979-09-17 | 1982-04-28 | Merck & Co Inc | Pharmaceutical composition comprising modified polyriboinosi-interferonin primates |
NZ194880A (en) | 1979-09-17 | 1983-07-15 | Merck & Co Inc | Interferon-inducing composition containing modified polyriboinosinic-polyribocytidylic acid |
JPS61103824A (ja) * | 1984-10-27 | 1986-05-22 | Nippon Kayaku Co Ltd | ポリリボイノシン酸・ポリリボシチヂル酸・ポリ−レ−リジン複合体の注射用製剤の新規調製法 |
JPS62252798A (ja) | 1986-01-06 | 1987-11-04 | Nippon Shinyaku Co Ltd | 核酸誘導体 |
US5298614A (en) | 1986-01-06 | 1994-03-29 | Nippon Shinyaku Co. Ltd. | Size limited double stranded poly I poly(cytidylate/4-thiouridylate) |
JPH01104094A (ja) * | 1987-07-03 | 1989-04-21 | Nippon Shinyaku Co Ltd | 核酸誘導体の製法及び製剤法 |
GB2207138B (en) | 1987-07-03 | 1992-02-05 | Nippon Shinyaku Co Ltd | Preparation of nucleic acid derivatives. |
US5698721A (en) * | 1992-12-17 | 1997-12-16 | Megabios Corporation | Catonic amphiphiles |
DE69422163T2 (de) | 1993-02-19 | 2000-06-15 | Nippon Shinyaku Co., Ltd. | Glycerolderivat, vorrichtung und pharmazeutische zusammensetzung |
US5908635A (en) * | 1994-08-05 | 1999-06-01 | The United States Of America As Represented By The Department Of Health And Human Services | Method for the liposomal delivery of nucleic acids |
EP0904031A4 (de) * | 1996-05-29 | 2002-05-02 | Cell Genesys Inc | Träger aus kationischem polymer und lipid zur verabreichung von nukleinsäuren |
US6217900B1 (en) * | 1997-04-30 | 2001-04-17 | American Home Products Corporation | Vesicular complexes and methods of making and using the same |
TW524693B (en) * | 1997-10-16 | 2003-03-21 | Nippon Shinyaku Co Ltd | Cancer cell nuclease activator |
KR100520738B1 (ko) * | 1998-03-24 | 2005-10-12 | 니뽄 신야쿠 가부시키가이샤 | 간염 치료제 |
-
1999
- 1999-05-24 KR KR1020007013233A patent/KR100644172B1/ko not_active IP Right Cessation
- 1999-05-24 EP EP99921242A patent/EP1086699B1/de not_active Expired - Lifetime
- 1999-05-24 RU RU2000132732/15A patent/RU2222334C2/ru not_active IP Right Cessation
- 1999-05-24 WO PCT/JP1999/002713 patent/WO1999061032A1/ja not_active Application Discontinuation
- 1999-05-24 DE DE69942581T patent/DE69942581D1/de not_active Expired - Lifetime
- 1999-05-24 JP JP2000550492A patent/JP3785932B2/ja not_active Expired - Fee Related
- 1999-05-24 CN CNB998065633A patent/CN1166366C/zh not_active Expired - Fee Related
- 1999-05-24 CA CA2333162A patent/CA2333162C/en not_active Expired - Fee Related
- 1999-05-24 AT AT99921242T patent/ATE473748T1/de not_active IP Right Cessation
- 1999-05-24 US US09/701,072 patent/US6545138B1/en not_active Expired - Fee Related
-
2002
- 2002-11-14 US US10/294,865 patent/US6746690B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3785932B2 (ja) | 2006-06-14 |
US6746690B2 (en) | 2004-06-08 |
US20030091622A1 (en) | 2003-05-15 |
CN1166366C (zh) | 2004-09-15 |
RU2222334C2 (ru) | 2004-01-27 |
CN1303293A (zh) | 2001-07-11 |
WO1999061032A1 (fr) | 1999-12-02 |
ATE473748T1 (de) | 2010-07-15 |
KR100644172B1 (ko) | 2006-11-10 |
EP1086699A1 (de) | 2001-03-28 |
US6545138B1 (en) | 2003-04-08 |
EP1086699B1 (de) | 2010-07-14 |
CA2333162C (en) | 2011-07-26 |
CA2333162A1 (en) | 1999-12-02 |
EP1086699A4 (de) | 2004-05-26 |
KR20010043803A (ko) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69942581D1 (de) | Verfahren zur herstellung einer nucleinsäure enthaltenden kompositzusammenstellung | |
DE69919019D1 (de) | Verfahren zur herstellung einer proteinzusammenzetzung und einer diese enthaltenden säuglingsnahrung | |
DE69832523D1 (de) | Polymere produkte enthaltend modifizierte kohlenstoffprodukte sowie verfahren zur herstellung und ihre verwendung | |
DE59913933D1 (de) | Ionenleitender, stoffdurchlässiger verbundwerkstoff, verfahren zu dessen herstellung und die verwendung des verbundwerkstoffes | |
DE59109172D1 (de) | Silane, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Polymerisaten und Polykondensaten | |
DE60229308D1 (de) | Verfahren zur Herstellung eines Fleischersatzproduktes, Fleischersatzprodukt erhältlich nach diesem Verfahren und gebrauchsfertiges Fleischersatzprodukt | |
DE69012039D1 (de) | Poly-hexamethylen-adipamid-Garn mit hoher Festigkeit und niedrigem Schrumpf und Verfahren zur Herstellung desselben. | |
ATE115607T1 (de) | Zusammensetzung und verfahren zur herstellung poröser gegenstände aus polyäthylen von ultra hohem molekulargewicht. | |
ATE35248T1 (de) | Flockungsmittel und seine herstellung. | |
DE60119711D1 (de) | Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen | |
DE60019805D1 (de) | Verfahren zur herstellung von orthokieselsäure, sowie nach dem verfahren hergestellte kieselsäure und ihre verwendung | |
ATE355861T1 (de) | Verfahren zur herstellung von absorbierenden sanitärartikeln mit milchsäure produzierenden bakterien | |
DE50000866D1 (de) | Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen | |
DE60020882D1 (de) | Verfahren zur herstellung eines hitzebeständiges, mesoporöses aluminophosphats mit hoher spezifischer oberfläche | |
DE60334875D1 (de) | Verfahren zur Herstellung von Fluorpolymerzusammensetzungen welche anorganische Nanopartikel enthalten | |
DE60335545D1 (de) | Wasserverdünnbare polymervorläufer sowie herstellung und verwendung davon | |
DE60028671D1 (de) | Verbesserte Polymerzusammensetzung und Verfahren zur Herstellung von Vulkanisaten damit | |
DE69903663D1 (de) | Verfahren zur herstellung einer silicasuspension in einer durch polykondensation zu kautschuk vernetzbaren siliconmatrix | |
DE69814164T2 (de) | Stabilisation von formen aus silikon-elastomer | |
KR20010026966A (ko) | 황토를 이용한 바닥재 제조방법 | |
DE60011408D1 (de) | Zusammensetzung oder expandierte mikroporöse struktur mit rascher auflösung , zur verwendung im pharmazeutischen, veterinärmedizinischen, diätetischen, kosmetischen und lebensmittel-bereich und verfahren zu seiner herstellung | |
DE10194268D2 (de) | Verfahren zur Herstellung wenigstens eines Körpers und fliessfähige Mischung zur Verwendung in einem solchen Verfahren | |
DE69020081D1 (de) | Verfahren zur Herstellung von 3,3',4,4'-Biphenyltetracarbonsäure von hoher Reinheit oder deren Dianhydrid. | |
DE60001285D1 (de) | Verfahren zur Herstellung einer Mischung von Mannit und Sorbit durch kontinuierliche Hydrierung von Glucoson | |
SE8802480D0 (sv) | Method of preparation of nucleic acid derivatives and method of preparation of medical composition containing the same |